Jonathan G Drachman - Net Worth and Insider Trading
Jonathan G Drachman Net Worth
The estimated net worth of Jonathan G Drachman is at least $40 Million dollars as of 2024-11-13. Jonathan G Drachman is the CMO & EVP, R & D of Seagen Inc and owns about 170,934 shares of Seagen Inc (SGEN) stock worth over $39 Million. Jonathan G Drachman is the President and CEO of Neoleukin Therapeutics Inc and owns about 119,934 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $418,570. Jonathan G Drachman is also the Director of Calithera Biosciences Inc and owns about 10,000 shares of Calithera Biosciences Inc (CALA) stock worth over $60. Details can be seen in Jonathan G Drachman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan G Drachman has not made any transactions after 2021-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan G Drachman
Jonathan G Drachman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan G Drachman owns 4 companies in total, including Neoleukin Therapeutics Inc (NLTX) , Calithera Biosciences Inc (CALA) , and Harpoon Therapeutics Inc (HARP) among others .
Click here to see the complete history of Jonathan G Drachman’s form 4 insider trades.
Insider Ownership Summary of Jonathan G Drachman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2021-08-25 | director & See Remarks |
| CALA | Calithera Biosciences Inc | 2021-11-10 | director |
| HARP | Harpoon Therapeutics Inc | 2019-02-07 | director |
 | | 2018-03-20 | See Remarks |
Jonathan G Drachman Latest Holdings Summary
Jonathan G Drachman currently owns a total of 3 stocks. Among these stocks, Jonathan G Drachman owns 170,934 shares of Seagen Inc (SGEN) as of March 5, 2018, with a value of $39 Million and a weighting of 98.94%. Jonathan G Drachman owns 119,934 shares of Neoleukin Therapeutics Inc (NLTX) as of August 25, 2021, with a value of $418,570 and a weighting of 1.06%. Jonathan G Drachman also owns 10,000 shares of Calithera Biosciences Inc (CALA) as of November 10, 2021, with a value of $60 and a weighting of 0%.
Latest Holdings of Jonathan G Drachman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2018-03-05 | 170,934 | 228.74 | 39,099,443 |
| NLTX | Neoleukin Therapeutics Inc | 2021-08-25 | 119,934 | 3.49 | 418,570 |
| CALA | Calithera Biosciences Inc | 2021-11-10 | 10,000 | 0.01 | 60 |
Holding Weightings of Jonathan G Drachman
Jonathan G Drachman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan G Drachman has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 10,457 shares on March 5, 2018, which brought Jonathan G Drachman around $552,443.
According to the SEC Form 4 filings, Jonathan G Drachman has made a total of 2 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Neoleukin Therapeutics Inc is the acquisition of 7,500 shares on August 25, 2021, which cost Jonathan G Drachman around $933,000.
According to the SEC Form 4 filings, Jonathan G Drachman has made a total of 1 transactions in Calithera Biosciences Inc (CALA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Calithera Biosciences Inc is the acquisition of 10,000 shares on November 10, 2021, which cost Jonathan G Drachman around $172,000.
Insider Trading History of Jonathan G Drachman
- 1
Jonathan G Drachman Trading Performance
GuruFocus tracks the stock performance after each of Jonathan G Drachman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan G Drachman is -27.93%. GuruFocus also compares Jonathan G Drachman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan G Drachman within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan G Drachman's insider trading performs compared to the benchmark.
Performance of Jonathan G Drachman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.64 | | | | | |
| Relative Return to S&P 500(%) | 0.35 | | | | | |
Jonathan G Drachman Ownership Network
Ownership Network List of Jonathan G Drachman
Ownership Network Relation of Jonathan G Drachman
Jonathan G Drachman Owned Company Details
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Jonathan G Drachman is the director & See Remarks of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Jonathan G Drachman made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
Jonathan G Drachman Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan G Drachman. You might contact Jonathan G Drachman via mailing address: 21823 30th Drive Se, Bothell Wa 98021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
